跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZIMAX-250 TABLET 250MG - HSA Drug Approval Details
Approvals
/
HSA
/
AZIMAX-250 TABLET 250MG
Approved
THERAPEUTIC
AZIMAX-250 TABLET 250MG
Hovid Bhd
🇸🇬 Health Sciences Authority
Approval Date
Aug 8, 2016
Approval ID
eaaf7df3f803354b
Company
Hovid Bhd
Type
Therapeutic
Approval Details
Approval Id
eaaf7df3f803354b
Drug Name
AZIMAX-250 TABLET 250MG
Product Name
AZIMAX-250 TABLET 250MG
Approval Number
SIN15065P
Approval Date
2016-08-08
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01FA10
Atc Item Name
azithromycin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Azithromycin dihydrate 262.05mg eqv Azithromycin
250mg
Azithromycin dihydrate 262.05mg eqv Azithromycin
250mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 8, 2016
Approval ID
eaaf7df3f803354b
Type
Therapeutic
Back to HSA Approvals